Abstract
Natural polyphenolic compounds have attractive consideration for their cancer preventive effect. As their anti-cancer effect, inhibitory effect on angiogenesis would be important. Recently, it has been shown that quercetin has anti-angiogenic activity and is a potent anti-cancer agent. However, the activity of its glycosylated forms and related derivatives has not been investigated yet. In this study, we examined the effect of glycosylated quercetin on angiogenesis. Interestingly, quercetin 3-O-β-D-glucose (isoquercitrin) showed the strongest inhibitory effect on an ex vivo angiogenesis assay, but quercetin 3-O-β-D-glucose-[1,6]-O-α-Lrhamnose (rutin) had no effect. Inhibitory effect of quercetin 7-O-β-D-glucose (quercimeritrin) was almost similar to that of quercetin. Furthermore, we compared the activity of acylated isoquercitrins (isoquercitrin cinnamate, dihydrocinnamate, p-coumarate, and 2-naphthalate). Consequently, anti-angiogenic activity of the isoquercitrin derivatives was weaker than that of isoquercitrin. The effects of quercetin and its derivatives on human umbilical endothelial cell (HUVEC) proliferation, HUVEC tube formation and chemotaxis assays were associated with their effects on the ex vivo angiogenesis assay.
Keywords: angiogenesis, quercetin, isoquercitrin, acylated isoquercitrin, rutin
Letters in Drug Design & Discovery
Title: Anti-Angiogenic Activity of Quercetin and its Derivatives
Volume: 1 Issue: 4
Author(s): Kiminori Matsubara, Kohji Ishihara, Yoshiyuki Mizushina, Masaharu Mori and Nobuyoshi Nakajima
Affiliation:
Keywords: angiogenesis, quercetin, isoquercitrin, acylated isoquercitrin, rutin
Abstract: Natural polyphenolic compounds have attractive consideration for their cancer preventive effect. As their anti-cancer effect, inhibitory effect on angiogenesis would be important. Recently, it has been shown that quercetin has anti-angiogenic activity and is a potent anti-cancer agent. However, the activity of its glycosylated forms and related derivatives has not been investigated yet. In this study, we examined the effect of glycosylated quercetin on angiogenesis. Interestingly, quercetin 3-O-β-D-glucose (isoquercitrin) showed the strongest inhibitory effect on an ex vivo angiogenesis assay, but quercetin 3-O-β-D-glucose-[1,6]-O-α-Lrhamnose (rutin) had no effect. Inhibitory effect of quercetin 7-O-β-D-glucose (quercimeritrin) was almost similar to that of quercetin. Furthermore, we compared the activity of acylated isoquercitrins (isoquercitrin cinnamate, dihydrocinnamate, p-coumarate, and 2-naphthalate). Consequently, anti-angiogenic activity of the isoquercitrin derivatives was weaker than that of isoquercitrin. The effects of quercetin and its derivatives on human umbilical endothelial cell (HUVEC) proliferation, HUVEC tube formation and chemotaxis assays were associated with their effects on the ex vivo angiogenesis assay.
Export Options
About this article
Cite this article as:
Matsubara Kiminori, Ishihara Kohji, Mizushina Yoshiyuki, Mori Masaharu and Nakajima Nobuyoshi, Anti-Angiogenic Activity of Quercetin and its Derivatives, Letters in Drug Design & Discovery 2004; 1 (4) . https://dx.doi.org/10.2174/1570180043398533
DOI https://dx.doi.org/10.2174/1570180043398533 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Voltammetric Sensing of Uremic Toxin Indoxyl Sulfate Using High Performance Disposable Screen-Printed Graphene Electrode
Current Pharmaceutical Analysis Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin
Current Medicinal Chemistry Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors
Medicinal Chemistry Anti-inflammatory and Hypolipidemic Effect of Novel Conjugates with Trolox and Other Antioxidant Acids
Medicinal Chemistry EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy Adeno-associated Viral Vectors for Correction of Inborn Errors of Metabolism: Progressing Towards Clinical Application
Current Pharmaceutical Design Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future
Central Nervous System Agents in Medicinal Chemistry Furosemide Protective Effect Against Airway Obstruction
Current Drug Targets AMPA Receptor Antagonists: Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Extraction of Quantitative Anatomical Information from Coronary Angiographies
Current Bioinformatics Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion
Current Medicinal Chemistry Preparation and Characterization of PEGylated C18 Fatty Acids/Anti-SNAP25 Antibody-Targeted Liposomes
Current Chemical Biology NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature
Anti-Cancer Agents in Medicinal Chemistry Derivatives of 6-Nitrobenzimidazole Inhibit Fructose-Mediated Protein Glycation and Intracellular Reactive Oxygen Species Production
Medicinal Chemistry Recent Advances in Fluorescent Probes for Monitoring of Hydrogen Sulfide
Current Medicinal Chemistry Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds
Medicinal Chemistry Pharmacological and Biological Activities of Benzazepines: An Overview
Current Bioactive Compounds COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Current Respiratory Medicine Reviews